IMNMHealthcareMid-Cap
Immunome Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for Immunome Inc. (IMNM), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Are IMNM insiders buying or selling?
Immunome Inc. insiders reported 29 open-market buys ($12.6M) and 12 sells ($21.8M) across 41 Form 4 filings — a net selling position of $9.3M.
Source: SEC EDGAR Form 4
Key Statistics (as of Jul 9, 2026)
Total Form 4 filings
41
SEC EDGAR
Insider filers
14
Insider buys (29)
$12.6M
Insider sells (12)
$21.8M
Insider sentiment
Net sellingNet insider flow of $9.3M in net selling. 1 insider buy in the last 90 days.
Recent IMNM insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 9, 2026 | Kinney Horn | CHIEF BUSINESS OFFICER | Sale | 1.1K | $25.00 | $27.3K |
| Jul 7, 2026 | Barchas Isaac | Director | Sale | 100.0K | $24.13 | $2.4M |
| Jul 7, 2026 | Robert Lechleider | Chief Medical Officer | Sale | 55.0K | $22.62 | $1.2M |
| Jul 3, 2026 | Barchas Isaac | Director | Sale | 201.1K | $21.85 | $4.4M |
| Jun 29, 2026 | Robert Lechleider | Chief Medical Officer | Sale | 55.0K | $19.85 | $1.1M |
| Jun 17, 2026 | Max Rosett | Chief Financial Officer | Sale | 60.0K | $18.23 | $1.1M |
| May 19, 2026 | Jean Jacques Bienaime | Director | Purchase | 5.0K | $20.70 | $103.5K |
| Apr 3, 2026 | Jack Higgins | Chief Scientific Officer | Sale | 9.4K | $21.64 | $204.2K |
| Apr 3, 2026 | Max Rosett | Chief Financial Officer | Sale | 65.0K | $21.92 | $1.4M |
| Mar 31, 2026 | Clay B Siegall | President and CEO | Purchase | 25.4K | $19.67 | $500.6K |
| Mar 24, 2026 | WAGENHEIM PHILIP | Director | Sale | 65.0K | $20.55 | $1.3M |
| Mar 12, 2026 | Jean Jacques Bienaime | Director | Purchase | 2.0K | $21.84 | $43.7K |
| Dec 30, 2025 | Clay B Siegall | President and CEO | Purchase | 4.7K | $21.15 | $100.0K |
| Dec 23, 2025 | Barchas Isaac | Director | Sale | 383.2K | $21.74 | $8.3M |
| Dec 22, 2025 | Clay B Siegall | President and CEO | Purchase | 7.3K | $20.48 | $149.1K |
| Dec 22, 2025 | Philip Tsai | Chief Technical Officer | Purchase | 10.0K | $20.49 | $204.9K |
| Dec 18, 2025 | Clay B Siegall | President and CEO | Purchase | 46.5K | $21.50 | $1000.0K |
| Jun 4, 2025 | Jean Jacques Bienaime | Director | Purchase | 5.0K | $9.38 | $46.9K |
| Mar 26, 2025 | Jean Jacques Bienaime | Director | Purchase | 7.8K | $7.78 | $60.7K |
| Mar 26, 2025 | Clay B Siegall | President and CEO | Purchase | 137.1K | $7.29 | $999.5K |
| Mar 25, 2025 | Jean Jacques Bienaime | Director | Purchase | 7.0K | $8.21 | $57.5K |
| Mar 25, 2025 | Philip Tsai | Chief Technology Officer | Purchase | 12.3K | $8.42 | $103.6K |
| Feb 4, 2025 | Clay B Siegall | President and CEO | Purchase | 150.0K | $7.75 | $1.2M |
| Nov 25, 2024 | Clay B Siegall | President and CEO | Purchase | 100.0K | $9.62 | $962.2K |
| Nov 25, 2024 | Robert Lechleider | Chief Medical Officer | Purchase | 15.8K | $9.48 | $149.8K |
Showing the 25 most recent of 41 Form 4 filings for Immunome Inc..
Most active IMNM insiders
- Clay B Siegall9 filings
- Jean Jacques Bienaime7 filings
- RAPP MICHAEL4 filings
- Barchas Isaac3 filings
- Max Rosett3 filings
Ask anything about IMNM insider activity
Use Trabud's AI agent to query Immunome Inc.'s Form 4 history in plain English — "Show me IMNM CEO purchases this year" or compare it against any other ticker.
Open the AI agentIMNM insider trading FAQ
Are Immunome Inc. insiders buying or selling?
Across 41 SEC Form 4 filings, Immunome Inc. (IMNM) insiders reported 29 open-market purchases totaling $12.6M and 12 sales totaling $21.8M. That is a net selling position of $9.3M.
How many insiders trade IMNM stock?
14 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Immunome Inc.. The most recent filing was accepted on Jul 9, 2026.
Where does Trabud get IMNM insider trading data?
All IMNM insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.